Rhythm Pharmaceuticals, Inc. SEC filings RYTM

Rhythm Pharmaceuticals, Inc. has 837 filings in SEC EDGAR's recent list, going back to Aug 12, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Rhythm Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material May 29, 2026 —
DEFA14A Additional proxy material May 5, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 24, 2026
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 24, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 24, 2025
DEFA14A Additional proxy material Aug 7, 2024 —
DEFA14A Additional proxy material Jun 17, 2024 —
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 18, 2024
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 21, 2023
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 8, 2022
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 9, 2021
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 17, 2020
DEF 14A Proxy statement Apr 30, 2019 Jun 19, 2019
DEF 14A Proxy statement Apr 30, 2018 Jun 6, 2018

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RYTM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Large accelerated filer
SEC CIK
1649904
Former names
RHYTHM METABOLIC, INC. (until Aug 12, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.